Vimarsana
Biggest News Aggregation in the World

Page 2 - Ashu Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ashu Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ashu Singhal Today - Breaking & Trending Today

Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development - Vimarsana News

Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development

/PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, today launched the industry's first full set of capabilities for designing,...

Why you must build a moat around early customers, according to Benchling's CEO and co-founder – TechCrunch - Vimarsana News

Why you must build a moat around early customers, according to Benchling's CEO and co-founder – TechCrunch

Benchling’s unicorn status didn’t come overnight. Some ten years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The company’s future looks like its past: talking to customers and building for power users. To that end, Benchling announced today that it recently […]

Microsoft Teams Integrations for Digital Workplaces - Vimarsana News

Microsoft Teams Integrations for Digital Workplaces

The COVID-19 pandemic and limitations that followed resulted in millions of people working remotely, disrupting the traditional way of working.

Source: hngn.com
Is The Great Resignation A Threat To Your Industry? - Vimarsana News

Is The Great Resignation A Threat To Your Industry?

In this article, we discuss how the great resignation is affecting the workforce and how it can be damaging for the industry.

40th Anniversary Recollections & Predictions - Vimarsana News

40th Anniversary Recollections & Predictions

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences.